
FDA staff flags eye safety risks for GSK’s blood cancer drug
Audio By Carbonatix By Sneha S K and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration’s staff reviewers on Tuesday raised safety concerns that GSK’s blood cancer drug Blenrep, when used in combination with other treatments, may cause eye …